45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
6,498
Insurances with rates
5
CPT / HCPCS codes
6,253
Source MRF
Most expensive procedures (gross)
J2326
$741,229
NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION
Gross
$1,482,459
J1305
$226,743
EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION
Gross
$453,486
C9293
$221,323
GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION
Gross
$442,646
J9228
$164,253
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$328,506
J9269
$156,150
TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION
Gross
$312,299
J3357
$151,988
USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE
Gross
$303,977
J9348
$140,117
NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION
Gross
$280,233
J2350
$110,958
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$221,915
J9274
$94,745
TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION
Gross
$189,490
J1303
$92,822
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION
Gross
$185,645
J9334
$86,475
EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN
Gross
$172,951
J9266
$86,056
PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION
Gross
$172,113
J0202
$81,601
ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION
Gross
$163,202
J3357
$75,994
USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$151,989
J9298
$69,953
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION
Gross
$139,906
J9043
$66,434
CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION
Gross
$132,868
J9038
$62,094
AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION
Gross
$124,188
J1744
$59,918
ICATIBANT 30 MG/3 ML SUBCUTANEOUS SYRINGE
Gross
$119,836
J2329
$59,729
UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION
Gross
$119,458
J9382
$54,947
ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$109,894
J2840
$54,891
SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION
Gross
$109,783
J9272
$54,574
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION
Gross
$109,148
J9307
$54,420
PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$108,840
J0222
$52,607
PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION
Gross
$105,214
J9022
$52,065
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$104,129
J2267
$51,576
MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$103,152
J9119
$49,081
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION
Gross
$98,163
J2323
$45,903
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$91,805
J2997
$45,895
ALTEPLASE 100 MG INTRAVENOUS SOLUTION
Gross
$91,791
J1930
$43,581
LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE
Gross
$87,161
J9228
$41,082
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$82,164
J9301
$39,859
OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION
Gross
$79,718
J9325
$37,545
TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION
Gross
$75,090
J2427
$36,474
PALIPERIDONE PALMITATE (3 MONTH) 546 MG/1.75 ML INTRAMUSCULAR SYRINGE
Gross
$72,948
J9022
$36,453
ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$72,906
J9210
$35,916
EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION
Gross
$71,833
J9063
$35,666
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION
Gross
$71,331
J1323
$34,970
ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION
Gross
$69,940
J0584
$33,446
BUROSUMAB-TWZA 20 MG/ML SUBCUTANEOUS SOLUTION
Gross
$66,892
J9332
$33,286
EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION
Gross
$66,572
J9333
$32,938
ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION
Gross
$65,876
J9303
$32,532
PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION
Gross
$65,064
J9306
$31,570
PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION
Gross
$63,140
J9307
$31,417
PRALATREXATE 20 MG/ML (1 ML) INTRAVENOUS SOLUTION
Gross
$62,835
J1932
$31,306
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE
Gross
$62,612
J1299
$30,194
ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION
Gross
$60,388
J0517
$27,814
BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE
Gross
$55,627
J2427
$27,354
PALIPERIDONE PALMITATE (3 MONTH) 410 MG/1.32 ML INTRAMUSCULAR SYRINGE
Gross
$54,709
J2267
$27,029
MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR
Gross
$54,058
J9271
$26,767
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION
Gross
$53,534
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2326 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $1,482,459 | $741,229 | — | — | 4 |
| J1305 | EVINACUMAB-DGNB 150 MG/ML INTRAVENOUS SOLUTION | $453,486 | $226,743 | — | — | 5 |
| C9293 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $442,646 | $221,323 | — | — | 2 |
| J9228 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION | $328,506 | $164,253 | — | — | 1 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $312,299 | $156,150 | — | — | 1 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $303,977 | $151,988 | — | — | 3 |
| J9348 | NAXITAMAB-GQGK 4 MG/ML INTRAVENOUS SOLUTION | $280,233 | $140,117 | — | — | 2 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $221,915 | $110,958 | — | — | 2 |
| J9274 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $189,490 | $94,745 | — | — | 4 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $185,645 | $92,822 | — | — | 8 |
| J9334 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $172,951 | $86,475 | — | — | 3 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $172,113 | $86,056 | — | — | 1 |
| J0202 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $163,202 | $81,601 | — | — | 1 |
| J3357 | USTEKINUMAB 45 MG/0.5 ML SUBCUTANEOUS SYRINGE | $151,989 | $75,994 | — | — | 3 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $139,906 | $69,953 | — | — | 4 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $132,868 | $66,434 | — | — | 2 |
| J9038 | AXATILIMAB-CSFR 50 MG/ML INTRAVENOUS SOLUTION | $124,188 | $62,094 | — | — | 4 |
| J1744 | ICATIBANT 30 MG/3 ML SUBCUTANEOUS SYRINGE | $119,836 | $59,918 | — | — | 15 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $119,458 | $59,729 | — | — | 2 |
| J9382 | ZENOCUTUZUMAB-ZBCO 375 MG/18.75 ML (20 MG/ML) INTRAVENOUS SOLUTION | $109,894 | $54,947 | — | — | 6 |
| J2840 | SEBELIPASE ALFA 2 MG/ML INTRAVENOUS SOLUTION | $109,783 | $54,891 | — | — | 2 |
| J9272 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $109,148 | $54,574 | — | — | 1 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $108,840 | $54,420 | — | — | 5 |
| J0222 | PATISIRAN (LIPID COMPLEX) 2 MG/ML INTRAVENOUS SOLUTION | $105,214 | $52,607 | — | — | 2 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $104,129 | $52,065 | — | — | 3 |
| J2267 | MIRIKIZUMAB-MRKZ 300 MG/15 ML (20 MG/ML) INTRAVENOUS SOLUTION | $103,152 | $51,576 | — | — | 4 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $98,163 | $49,081 | — | — | 2 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $91,805 | $45,903 | — | — | 4 |
| J2997 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION | $91,791 | $45,895 | — | — | 5 |
| J1930 | LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE | $87,161 | $43,581 | — | — | 2 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $82,164 | $41,082 | — | — | 1 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $79,718 | $39,859 | — | — | 1 |
| J9325 | TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION | $75,090 | $37,545 | — | — | 0 |
| J2427 | PALIPERIDONE PALMITATE (3 MONTH) 546 MG/1.75 ML INTRAMUSCULAR SYRINGE | $72,948 | $36,474 | — | — | 6 |
| J9022 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION | $72,906 | $36,453 | — | — | 2 |
| J9210 | EMAPALUMAB-LZSG 5 MG/ML INTRAVENOUS SOLUTION | $71,833 | $35,916 | — | — | 4 |
| J9063 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION | $71,331 | $35,666 | — | — | 3 |
| J1323 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $69,940 | $34,970 | — | — | 9 |
| J0584 | BUROSUMAB-TWZA 20 MG/ML SUBCUTANEOUS SOLUTION | $66,892 | $33,446 | — | — | 8 |
| J9332 | EFGARTIGIMOD ALFA-FCAB 20 MG/ML INTRAVENOUS SOLUTION | $66,572 | $33,286 | — | — | 2 |
| J9333 | ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION | $65,876 | $32,938 | — | — | 5 |
| J9303 | PANITUMUMAB 400 MG/20 ML (20 MG/ML) INTRAVENOUS SOLUTION | $65,064 | $32,532 | — | — | 3 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $63,140 | $31,570 | — | — | 5 |
| J9307 | PRALATREXATE 20 MG/ML (1 ML) INTRAVENOUS SOLUTION | $62,835 | $31,417 | — | — | 2 |
| J1932 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $62,612 | $31,306 | — | — | 2 |
| J1299 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $60,388 | $30,194 | — | — | 1 |
| J0517 | BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE | $55,627 | $27,814 | — | — | 2 |
| J2427 | PALIPERIDONE PALMITATE (3 MONTH) 410 MG/1.32 ML INTRAMUSCULAR SYRINGE | $54,709 | $27,354 | — | — | 2 |
| J2267 | MIRIKIZUMAB-MRKZ 100 MG/ML SUBCUTANEOUS PEN INJECTOR | $54,058 | $27,029 | — | — | 9 |
| J9271 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION | $53,534 | $26,767 | — | — | 4 |
Showing top 50 of 6,498 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.